ANEBULO PHARMACEUTICALS INC (ANEB) Stock Income Statement
USA - NASDAQ:ANEB - US0345691036 - Common Stock
2.71 USD
+0.02 (+0.74%)
2.75 USD
+0.04 (+1.48%)
| 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 9.22M | 8.31M | 11.78M | 6.83M | 3.61M | |||
| Research and Development | 4.30M | 3.55M | 5.60M | 2.96M | 2.27M | |||
| Selling, General, and Administrative Expenses | 4.92M | 4.76M | 6.18M | 3.87M | 1.34M | |||
| Operating Income | -9.22M | -8.31M | -11.78M | -6.83M | -3.61M | |||
| Interest Income/Expense | -124.10K | 97.80K | 90.00K | 10.00K | -26.64M | |||
| Other Income/Expense | 862.80K | 9.30K | -40.00K | 0.00 | 0.00 | |||
| Income Before Taxes | -8.48M | -8.20M | -11.73M | -6.83M | -30.25M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -8.48M | -8.20M | -11.73M | -6.83M | -38.46M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.25 | -0.32 | -0.47 | -0.29 | -1.65 | |||
| Non GAAP EPS | -0.26 | -0.32 | -0.47 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD